[go: up one dir, main page]

MX2019000715A - Composiciones nutritivas y formulas infantiles que comprenden una mezcla de oligosacaridos y, opcionalmente, bifidobacterium lactis para prevenir, tartar o reducir la gravedad de la diarrea asociada a no rotavirus. - Google Patents

Composiciones nutritivas y formulas infantiles que comprenden una mezcla de oligosacaridos y, opcionalmente, bifidobacterium lactis para prevenir, tartar o reducir la gravedad de la diarrea asociada a no rotavirus.

Info

Publication number
MX2019000715A
MX2019000715A MX2019000715A MX2019000715A MX2019000715A MX 2019000715 A MX2019000715 A MX 2019000715A MX 2019000715 A MX2019000715 A MX 2019000715A MX 2019000715 A MX2019000715 A MX 2019000715A MX 2019000715 A MX2019000715 A MX 2019000715A
Authority
MX
Mexico
Prior art keywords
composition
severity
rotavirus
oligosaccharides
mix
Prior art date
Application number
MX2019000715A
Other languages
English (en)
Inventor
Berger Bernard
Bruessow Harald
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56571248&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019000715(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2019000715A publication Critical patent/MX2019000715A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A23V2250/284—Oligosaccharides, non digestible

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención se relaciona con una composición nutritiva que comprende al menos un oligosacárido N-acetilado, y al menos un galactooligosacárido, y al menos un oligosacárido sialilado. La composición comprende, opcionalmente, un probiótico Bifidobacterium animalis spp. lactis, preferentemente, un probiótico CNCM-l-3446. La composición trata o reduce el riesgo, la gravedad y/o la aparición de diarrea asociada a no rotavirus. La composición promueve, además, una flora intestinal saludable y tiene efectos beneficiosos a corto y largo plazo. La composición está destinada en particular para infantes entre 0 y 12 meses de edad alimentados predominantemente con fórmulas infantiles.
MX2019000715A 2016-08-04 2017-07-06 Composiciones nutritivas y formulas infantiles que comprenden una mezcla de oligosacaridos y, opcionalmente, bifidobacterium lactis para prevenir, tartar o reducir la gravedad de la diarrea asociada a no rotavirus. MX2019000715A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16182797 2016-08-04
PCT/EP2017/067019 WO2018024440A1 (en) 2016-08-04 2017-07-06 Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea

Publications (1)

Publication Number Publication Date
MX2019000715A true MX2019000715A (es) 2019-06-20

Family

ID=56571248

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000715A MX2019000715A (es) 2016-08-04 2017-07-06 Composiciones nutritivas y formulas infantiles que comprenden una mezcla de oligosacaridos y, opcionalmente, bifidobacterium lactis para prevenir, tartar o reducir la gravedad de la diarrea asociada a no rotavirus.

Country Status (9)

Country Link
US (1) US20190166897A1 (es)
EP (1) EP3493686B1 (es)
CN (1) CN109561723A (es)
AU (2) AU2017307952A1 (es)
ES (1) ES2992190T3 (es)
MX (1) MX2019000715A (es)
PH (1) PH12018502382A1 (es)
RU (1) RU2748279C2 (es)
WO (1) WO2018024440A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018024440A1 (en) 2016-08-04 2018-02-08 Nestec Sa Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
CN113825411A (zh) 2019-05-17 2021-12-21 纽崔西亚公司 包含维生素a和非消化性低聚糖的组合物
CN112870233B (zh) * 2019-11-29 2024-08-23 伊利伊诺科技(上海)有限责任公司 包含乳双歧杆菌与母乳低聚糖的组合物及其应用
BE1028802B1 (fr) * 2020-11-16 2022-06-14 Le Centre Wallon De Rech Agronomiques Développement d'une composition symbiotique comme un additif d'alimentation pour les porcelets ou les truies gestantes pour moduler le microbiote intestinal des porcelets au temps du sevrage
CN114504109B (zh) * 2020-11-16 2024-02-09 内蒙古伊利实业集团股份有限公司 一种含乳双歧杆菌与母乳低聚糖的组合物及其应用
CN113088465B (zh) * 2021-04-02 2022-03-22 湖北均瑶大健康饮品股份有限公司 一种乳双歧杆菌Bifidobacterium lactis菌株J605及其应用
CN114146100B (zh) * 2021-11-22 2023-04-07 微康益生菌(苏州)股份有限公司 动物双歧杆菌乳亚种(Bifidobacterium animalis subsp.lactis)BLa80在制备抗轮状病毒感染致腹泻的药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
FI112586B (fi) 2002-06-25 2003-12-31 Vieskan Metalli Oy Suorakylvökone
EP1926394B1 (en) 2005-02-21 2020-02-19 Société des Produits Nestlé S.A. Oligosaccharide mixture
CN104223094A (zh) * 2005-02-28 2014-12-24 纽崔西亚公司 具有益生菌的营养组合物
RU2432090C2 (ru) * 2006-01-31 2011-10-27 Нестек С.А. Питательная композиция
AU2007222598B2 (en) * 2006-03-07 2013-01-10 Société des Produits Nestlé S.A. Synbiotic mixture
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2009082214A1 (en) * 2007-12-21 2009-07-02 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
CA2725051A1 (en) * 2008-05-27 2009-12-03 Nestec S.A. Probiotics to improve gut microbiota
WO2012024638A2 (en) 2010-08-20 2012-02-23 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
BR112013016914A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica
EP2526784A1 (en) 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
BR112014007829A2 (pt) 2011-10-18 2017-04-18 Nestec Sa composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio
AU2014350157A1 (en) * 2013-11-15 2016-04-14 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
CN105899089A (zh) 2013-12-19 2016-08-24 雀巢产品技术援助有限公司 用于减少婴儿代谢应激、降低肠道通透性和接近母乳喂养婴儿的生长速度的营养组合物
US20170332691A1 (en) 2014-10-27 2017-11-23 Nestec S.A. Nutritional compositions comprising sn-1 (3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or young children
MX385648B (es) 2015-08-04 2025-03-18 Soc Des Produits Nestle S A Star Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
AU2016374150A1 (en) 2015-12-18 2018-04-26 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants
WO2018024440A1 (en) 2016-08-04 2018-02-08 Nestec Sa Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea

Also Published As

Publication number Publication date
EP3493686A1 (en) 2019-06-12
RU2019105764A (ru) 2020-09-04
AU2022203298A1 (en) 2022-06-02
RU2019105764A3 (es) 2020-09-04
PH12018502382A1 (en) 2019-04-08
ES2992190T3 (es) 2024-12-10
RU2748279C2 (ru) 2021-05-21
AU2017307952A1 (en) 2018-11-29
EP3493686B1 (en) 2024-03-27
WO2018024440A1 (en) 2018-02-08
US20190166897A1 (en) 2019-06-06
CN109561723A (zh) 2019-04-02
AU2022203298B2 (en) 2024-07-04

Similar Documents

Publication Publication Date Title
PH12018502382A1 (en) Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
MX2025003470A (es) Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
MX2025009008A (es) Cepas bacterianas probioticas que producen acidos grasos de cadena corta y composiciones que las comprenden
NZ771554A (en) Nutritional composition for promoting intestinal health
MY187630A (en) Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics
MY169058A (en) Method for stimulating the intestinal flora
RU2013128595A (ru) Смесь олигосахаридов и продукт питания, содержащий эту смесь, в частности питательная смесь для кормления младенцев
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12018501299A1 (en) Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic scfa production and/or by increasing glp-1 secretion
RU2013128594A (ru) Композиция для применения с целью предупреждения и/или лечения состояний кожи и заболеваний кожи
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
PH12014500509B1 (en) Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
MY159076A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
MX2019011058A (es) Moleculas probioticas para reducir virulencia patogena.
PH12017550041A1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
MX2019005343A (es) Composiciones nutricionales que proporcionan manejo dietetico de colicos.
MX2024000566A (es) Composicion probiotica para el tratamiento del aumento de la permeabilidad intestinal.
MX2019015306A (es) Probioticos y metodos de uso.
MY197917A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2024013999A (es) Composicion nutricional que comprende gos y hmo
MX2023006086A (es) Métodos para prevenir, retrasar o aliviar enfermedades atópicas.